Philips partners with Orbita to develop conversational voice and chatbot applications to complement its telehealth solutions
March 29 2021 - 09:00AM
Philips partners with Orbita to develop conversational voice and
chatbot applications to complement its telehealth solutions
March 29, 2021
Partnership to create AI-based virtual assistants with the human
touch needed for effective remote patient engagement
Amsterdam, the Netherlands and Boston, U.S. –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, and Orbita Inc., an innovative provider of
conversational artificial intelligence (AI) solutions for
healthcare, today announced a partnership agreement to co-create
next-generation conversational virtual assistants for Philips’
consumer health and patient support applications. The joint
development agreement will see Orbita’s technology rolled out to
digital health applications that enhance the patient experience and
increase efficiency throughout the health continuum.
Orbita, a U.S.-based company, provides healthcare, life-science,
and medical technology organizations with HIPAA-compliant chatbots
and voice assistants for ‘digital front door’ applications, remote
and in-facility patient support, pre- and post-visit outreach, and
other healthcare applications. Its conversational platform allows
developers and non-technical staff to quickly build and easily
manage cloud-based virtual assistants that are seamlessly
deployable to smart speakers, web and mobile chat apps, short
message service (SMS) and interactive voice response (IVR)
services, as well as custom devices.
“With the acceleration in the adoption of telehealth during the
COVID-19 pandemic, AI-enabled voice services, virtual assistants
and chatbots are already playing an enabling role in driving 24/7
access to healthcare, enhancing patient engagement, and improving
clinical efficiency,” said Henk van Houten, Chief Technology
Officer and Head of Philips Research. "Orbita is a not only a
leader and innovator in voice and chat-powered virtual assistants
that deliver the human touch needed in healthcare, but also a
company that can keep up with the rapid pace of telehealth
innovation that Philips is determined to pursue.”
“We are extremely excited to be expanding our partnership with
Philips, one of the largest and most innovative digital health
technology companies in the world,” said Nathan Treloar, President
and Chief Operating Officer at Orbita. “Philips’ presence in the
industry means they are at the forefront of healthcare’s most
demanding challenges, where the greatest opportunities exist to
apply the unique capabilities of Orbita’s products and
solutions.”
Philips believes that AI has the potential to improve people’s
lives across the health continuum – from healthy living and
prevention to diagnosis, treatment, and home care – provided it is
applied with a deep understanding of people's lives, and the
clinical and operational context in which healthcare providers
operate. Its partnership with Orbita, a company that has a proven
track record of successfully applying AI-enabled conversational
virtual assistants in healthcare applications, is part of Philips’
overall strategy to leverage cutting-edge AI wherever it can help
deliver on the Quadruple Aim of healthcare. Examples where Philips
is already using AI can be found in its personal health, diagnosis
and treatment, and connected care offerings. Examples of Orbita’s
solutions include patient acquisition and engagement portals,
virtual bedside assistants, and virtual care continuity
assistants.
Philips owns a minority interest in Orbita through its Health
Technology Venture Fund since May of 2020. Philips Health
Technology Ventures manages a business-agnostic digital health fund
that invests in, and partners with, promising healthcare
informatics and health technology start-up companies to accelerate
their growth and extend their reach. Active partnerships, such as
the one announced today with Orbita, are an essential part of
Philips’ goal to develop integrated solutions that enable
healthcare providers to deliver on the Quadruple Aim – better
health outcomes, better patient and staff experiences, and lower
cost of care.
For further information, please contact:
For Philips:Ben ZwirsPhilips Global Press
OfficeTel.: +31 6 1521 3446E-mail: ben.zwirs@philips.com
For Orbita Inc.:Julia SearcyMERGETel.: +1
678.879.1929E-mail: jsearcy@mergeworld.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
About Orbita Inc.Orbita's award-winning,
HIPAA-compliant conversational AI platform powers voice and chat
solutions for healthcare and life sciences organizations that
improve patient engagement, increase clinical efficiency, and
improve outcomes. Customers include innovative organizations like
Mass General Brigham, Mayo Clinic, Amwell, Yale New Haven Hospital,
Cancer Treatment Centers of America, University of Chicago
Medicine, and a portfolio of pharmaceutical clients. Partners
include Cognizant, Deloitte, Pariveda, and ServiceNow. Find us at
orbita.ai, contact us at hello@orbita.ai.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2023 to Mar 2024